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ABSTRACT: Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid
droplets and aerosols. Face masks and other personal protective equipment (PPE) can
act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2
are stable for hours on various materials, which makes frequent and correct disposal of
these PPE important. Metal ions embedded into PPE may inactivate respiratory
viruses, but confounding factors such as adsorption of viruses make measuring and
optimizing the inactivation characteristics difficult. Here, we used polyamide 6.6
(PA66) fibers containing embedded zinc ions and systematically investigated if these
fibers can adsorb and inactivate SARS-CoV-2 and IAV H1N1 when woven into a fabric.
We found that our PA66-based fabric decreased the IAV H1N1 and SARS-CoV-2 titer
by approximately 100-fold. Moreover, we found that the zinc content and the virus
inactivating property of the fabric remained stable over 50 standardized washes.
Overall, these results provide insights into the development of reusable PPE that offer
protection against RNA virus spread.
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■ INTRODUCTION
Infections with influenza A viruses (IAV), influenza B viruses,
and coronaviruses (CoV) are a burden on our healthcare
systems and economy. These respiratory RNA viruses transmit
through aerosols, liquid droplets, and fomites and typically
cause a mild disease with symptoms including nasopharyngitis,
fever, coughing, and headache. In addition, IAV and CoV
strains can cause pandemics with even graver death tolls and
economic consequences. The most recent example is the
SARS-CoV-2 pandemic strain, the causative agent of CoV
Disease 2019 (COVID-19).1 Understanding how we can
efficiently prevent the spread of these viruses will be important
for current and future RNA virus outbreaks.
An IAV particle consists of a double-layered membrane in
which multiple copies of the viral hemagglutinin (HA), matrix
2 (M2), and neuraminidase (NA) proteins are embedded.2
The viral RNA genome resides inside the membrane and
consists of eight negative-sense single-stranded RNA segments
that are encapsidated by the viral nucleoprotein (NP) and
RNA polymerase as ribonucleoprotein (RNP) complexes.3
The SARS-CoV-2 virion consists of a double-layered
membrane and the membrane proteins spike (S), envelope
(E), and matrix (M). In contrast to IAV, the SARS-CoV-2
genome is a non-segmented positive-sense RNA that is bound
by the viral nucleocapsid protein (N).4,5 Infection of a host cell
requires binding of the SARS-CoV-2 S protein to the cellular
receptor ACE2, while IAV uses its HA protein to bind sialic
acid receptors.6
While antivirals and vaccines are available for the treatment
and containment of IAV and SARS-CoV-2 infections,7−10 the
approaches may not be effective against future emerging
strains.11,12 The use of personal protective equipment (PPE),
such as face masks, is therefore recommended to reduce the
spread of novel respiratory viruses.13−15 However, PPE require
careful decontamination to allow their re-use because
respiratory viruses are stable for days to hours on fabrics.16−21
Development of PPE that can trap and inactivate respiratory
viruses may help address some of these concerns.
Previous research has shown that IAV and CoV can be
inactivated by silver nanoparticles, copper nanoparticles,
cuprous oxide (Cu2O) or cupric oxide (CuO) spays, and
copper or zinc surfaces or fibers.22−28 While the underlying
inactivation mechanisms are not fully understood, evidence
suggests that metal ions can induce RNA hydrolysis,
membrane destabilization, or viral protein inactivation and
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degradation.29−31 So far, few studies have investigated if metal
ions embedded in fabrics can inactivate RNA viruses, in part
because absorbance and fabric density differences present
confounding factors that inactivation protocols do not account
for.
We here show how we can remove IAV H1N1 and
pandemic SARS-CoV-2 from a woven PA66 fabric to measure
the number of remaining active viruses. Using this advance-
ment, we find that a zinc-containing PA66-based fabric
decreased the IAV H1N1 and pandemic SARS-CoV-2 titer
by approximately 2-logs. This reduction is more than sufficient
to inactivate the number of infectious IAV particles (∼24
plaque-forming units [pfu]) present in a cough.32 Overall,
these results provide new insights into the development of
testing protocols for “pathogen-free” fabrics.
■ RESULTS
Influenza Virus Adsorbance by Cotton, Polypropy-
lene, and Polyamide. Fabrics vary by their filtration
properties, breathability, hydrophobicity, electrostaticity, and/
or weight per square meter (gram/m2). In addition, fabrics can
have different moisture retention abilities depending on
environmental conditions.33 These different properties affect
how fabrics trap and/or release aerosols or liquid droplets
containing respiratory RNA viruses. Presently, it is not fully
understood how moisture retention is correlated with virus
particle adsorption. To investigate this relationship, we added
IAV strain A/WSN/33 (H1N1) to International Antimicrobial
Council (IAC) issued cotton, a textile PA66 fabric, or
polypropylene (PPP) from a disposable type II 3-ply face
mask (Figure 1A). After a 30 min of incubation at room
temperature, the fabrics were washed with phosphate-buffered
saline (PBS) to remove virus that had not been adsorbed
(Figure 1B). To estimate the amount of remaining liquid on
each fabric, each sample tube with fabric was weighed and
compared to its dry weight. As shown in Figure 1C,D, cotton
and PA66 retained more liquid than PPP, both relative to the
applied volume and the weight of the fabric. Subsequent
analysis of the IAV titer in the input and fabric washes showed
that the cotton and woven PA66 fabrics readily adsorbed the
applied virus, while less virus was adsorbed by the PPP fabric
(Figure 1E,F), which is in line with the higher hydrophobicity
of PPP relative to PA66 and cotton.34
To remove IAV from the cotton and PA66 fabrics without
inactivating the virus, we added different concentrations of
polysorbate-80 (tween-80)a mild detergent that is also used
in IAV vaccine preparationsto the PBS wash buffer (Figure
1G). We did not observe any cytopathic effects of the
detergent on the Madin−Darby Canine Kidney (MDCK) cells
when diluted in MEM for plaque assays. Interestingly, we did
find that the presence of 0.05−0.1% tween-80 increased the
apparent viral titer relative to infections in PBS (Figure 1G),
whereas 0.25−0.5% tween-80 reduced the apparent IAV
plaque size (Figure 1G). In addition, we found that 0.05%
tween-80 in PBS succeeded in recovering more than 94% of
the virus from the PA66 woven fabric, whereas 61% was
removed from the cotton fabric (Figure 1H,I). No virus
plaques were recovered when we used 1% or higher
concentrations of tween-80, likely because tween-80 destabi-
lized the membrane or membrane-embedded glycoproteins of
the virus particles (Figure 1I).
We next measured if SARS-CoV-2 could be removed from
cotton and woven PA66 and found that over 92% of SARS-
CoV-2 can be recovered from the woven PA66 fabric using
0.05% tween-80, while up to 59% could be recovered from the
cotton fabric (Figure 1J). Together, these results demonstrate
that IAV and SARS-CoV-2 in liquid suspension are strongly
adsorbed by cotton and PA66, suggesting that these materials
would trap respiratory viruses inside face masks. At the same
time, these findings imply that PPP is poor at trapping
Figure 1. Adsorption and release of IAV and SARS-CoV-2 from
fabrics. (A) Photographs of cotton control, PA66, and PPP fabric
samples. (B) Schematic of experimental procedure for exposing and
isolating RNA virus from fabrics. (C) Analysis of virus medium
retention by fabrics per volume of input medium. Values were
obtained by weighing each fabric before and after addition of virus
medium and after removal of the virus medium. (D) Analysis of virus
medium retention by fabrics normalized by dry weight of each fabric.
Values were obtained by weighing each fabric before and after
addition of virus medium and after removal of the virus medium. (E)
Plaque assay of IAV present in virus medium after removal of the
medium from each fabric. (F) Quantitation of the amount of virus
remaining on each fabric, normalized by the dry weight of each fabric.
(G) Effect of different tween-80 concentrations on IAV plaque assay
read-out. (H) Effect of 0.05% tween-80 in PBS on the amount of virus
released from each fabric. (I) Quantitation of IAV titers after
adsorption of the virus to the fabrics and washing of the fabrics with
PBS or PBS containing different concentrations of tween-80. (J)
Quantitation of SARS-CoV-2 titers after adsorption of the virus to the
fabrics and washing of the fabrics with PBS or PBS containing
different concentrations of tween-80. Error bars indicate standard
deviation. Asterisk indicates p-value, with *p < 0.05, **p < 0.005, and
ns p > 0.05.
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respiratory viruses. Since IAV and SARS-CoV-2 can be
removed from a PA66 fabric with a mild detergent, this
protocol can be useful for testing the inactivating properties of
fabrics.
Influenza Virus Is Inactivated by Zinc Ions. Copper and
zinc surfaces or particles can inactivate IAV strains, SARS-
CoV-2, and seasonal CoV HCoV-229E, and PPP imbued with
copper oxide can inactivate IAV.22,25,26,29,30,35 As an embedded
component of a polymer, zinc may provide at least three
benefits over copper. First, zinc has a much higher propensity
to ionize than copper, thereby providing a much faster reaction
potential. Second, zinc oxide is considered a Generally
regarded as Safe (GRAS) compound by the FDA, which can
speed up the development process. Third, zinc does not cause
discoloration of the polymer or fabric, enabling a broader
applicability. However, like copper, zinc ions are cytotoxic in
tissue culture (Figure 2A), which confounds analysis of their
effect on viral titers. We found that addition of an equimolar
concentration of EDTA following the virus incubation with
zinc ions (Figure 2B) can efficiently chelate zinc ions and
prevent cytotoxic effects (Figure 2C). EDTA alone does not
have any cytotoxic effects when diluted in a plaque assay and it
does not reduce viral titers (Figure 2A).
To investigate if zinc ions can directly inactivate IAV, we
incubated influenza virus with varying concentrations of zinc
chloride. After 60 min, the reactions were stopped with an
equimolar amount of EDTA and subsequently diluted for virus
titer determination by plaque assay (Figure 2B). As shown in
Figure 2D, we found that addition of zinc chloride resulted in a
significant reduction in the IAV titer. Previous research has
shown that metal ions can destabilize viral proteins and we
noted that the zinc chloride affected the pH of the incubation
medium.29 To gain more insights into the mechanism of virus
inactivation, viral protein levels in the zinc chloride-treated
samples were analyzed by western blot. As shown in Figure 2E,
we found that in the presence of zinc chloride, soluble HA
levels were reduced in a concentration-dependent manner,
while NP levels did not diminish (Figure 2E). This result thus
suggests that zinc ions may affect the IAV surface proteins
more significantly than the internal proteins. To test if IAV
RNA levels were affected, we added a 120-nucleotide long
spike RNA to each sample, extracted viral RNA, and performed
reverse transcriptions (RT) using a 3′ terminal NA primer.
cDNA levels were next quantified using quantitative polymer-
ase chain reaction (qPCR) of the NA gene-encoding segment
and normalized to the spike RNA level (Figure 2E). No effect
of zinc chloride on viral NA-encoding RNA segment levels was
found. Together, these results imply that zinc ions can
inactivate an IAV H1N1 strain by destabilization of the viral
surface proteins.
Construction of a Fabric Containing Zinc Oxide. The
above results suggest that zinc ions can directly inactivate an
IAV H1N1 strain. To investigate if these inactivating
properties are also present when zinc is embedded in a
PA66 matrix (Figure 3A), we first prepared zinc-containing
Figure 2. IAV is inactivated by zinc ions. (A) Plaque assay showing the effect of different zinc chloride and EDTA concentrations on IAV titers. (B)
Experimental approach for inactivating IAV with zinc ions and neutralization of zinc ions using EDTA. (C) Cytotoxicity analysis of zinc chloride
and EDTA in MDCK cells. (D) IAV titers after exposure to zinc chloride and neutralization with EDTA as measured on MDCK and Vero E6 cells.
(E) Western blot IAV HA and NP protein levels after exposure to zinc chloride and neutralization with EDTA. The upper panel shows quantitation
of western signal and the middle panel shows the western signal as detected with LI-COR. The bottom panel shows NA segment RT-qPCR analysis
of IAV after exposure to zinc chloride and neutralization with EDTA. Error bars represent standard deviation. Asterisk indicates p-value, with *p <
0.05, **p < 0.005, and ns p > 0.05.
Figure 3. Construction of zinc-containing fabric. (A) Model for virus
inactivation by zinc incorporated into fibers. A single PA66 unit is
colored orange. (B) Schematic of a melt spinning operation to
produce textile yarn. (C) SEM of zinc-containing fabric at 3,000×,
16,000×, 60,000×, and 140,000× magnification.
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PA66 polymer pellets by adding zinc ions from a zinc oxide
source to the polymerization step. Next, the PA66 pellets were
used to spin yarn (Figure 3B) and knit a single jersey fabric on
a circular knitting machine. Scanning electron microscopy
shows that no zinc oxide particles were visible in the polymer
at 140,000× magnification (Figure 3C). The resulting fabrics,
with internal code KF1, contained 328 ppm zinc ions and had
an air permeability of 111 cfm/sq ft (Table 1). As a control, we
also prepared a PA66 fabric that had similar characteristics but
did not contain zinc (Table 1).
To investigate if fabrics constructed from fibers containing
zinc maintain their zinc content after washing, we performed
two experiments. In the first, 1 kg of fabric with 500 ppm zinc
ions (equivalent to 5.3 mM; internal code KG6) was
submerged into a wash solution (AATCC procedure 1-2018)
and the wash water was retrieved after agitation. Next, the zinc
content was measured using inductively coupled plasma (ICP)
before and after capture of the zinc ion content using a cation
exchange resin. We measured that only 0.149 ppm zinc was
released from the fabric into the leachate and that all zinc
content was captured by the exchange resin (Table 2). In our
second experiment, we washed the fabric up to 50 times using
the standardized home laundry test protocol AATCC M6-
2016. Subsequent ICP-OES analysis of the zinc content in the
fabric after washing revealed that the zinc content remained
relatively stable in the PA66 fabrics during 50 washes (Table
3). Overall, these data suggest that the PA66 fibers contain
mostly zinc ions and that these zinc ions are stably maintained
in the fibers.
Influenza and Coronavirus Strains Are Inactivated on
Fabrics Containing Zinc Ions. We next incubated 0.4 g of
KF1 with virus and washed the fabrics using a PBS buffer
containing 0.05% tween-80 and 10 mM EDTA (PBSTE;
Figure 4A,B), which resulted in an approximately 2-log
reduction of the IAV and SARS-CoV-2 titers compared to a
PA66 control fabric after 1 h (Figure 4C,D). To confirm that
inactivation of these viruses occurred on KF1, the viral protein
levels were analyzed in the PBSTE wash eluate by western blot
(Figure 4E,F). Any virus that remained in the fabric after
extraction with PBSTE was lysed using Trizol and analyzed by
western blot. Western blots showed a reduction in the soluble
HA and S protein level in the virus eluate that was removed
from the KF1 fabric compared to the control fabric eluate for
IAV and SARS-CoV-2, respectively (Figure 4E,F). The signal
obtained from the virus that remained on each fabric after the
PBSTE extraction was close to background, in line with the
observations in Figure 1. We were only able to quantify the
SARS-CoV-2 signal but observed no statistically significant
difference.
Overall, we conclude that inactivation of IAV and SARS-
CoV-2 occurs on a fabric embedded with zinc oxide, analogous
to the previously observed effects of cupric and cuprous
oxide.25,26,35 To better investigate the rate of reduction, we
incubated KF1 with virus for different lengths of time and
subtracted the adsorbed virus titer in the negative control from
the level of reduction in the KF1 fabric and fitted the data with
a logarithmic equation (Figure 4G). A maximum rate of virus
titer reduction occurred between 30 s and 5 min of incubation,
and the virus titer reduction reached a plateau after
approximately 50 min.
Inactivation of IAV and Coronavirus Scales with Virus
Load. To investigate the robustness and saturation level of the
inactivation by fabrics containing embedded zinc oxide, we
next performed experiments with KF1 and varied the viral load
added to each fabric over a range of 103 to 107 pfu. The liquid
volume applied to each fabric was kept constant. After
incubation for different periods of time, fabrics were washed
with PBSTE, and the virus titers were estimated by plaque
assay. The virus titer reduction rate for the linear phase was
subsequently calculated based on the shortest incubation time.
Reduction rates were subsequently normalized by the dry
weight of each fabric. As shown in Figure 4G, the rate of
reduction in virus titer (in pfu·gram−1·min−1) scaled with virus
load. On a log−log plot, the data could be fit with a linear
equation. To confirm the robustness of these findings, we
performed the same experiments with SARS-CoV-2 and found
a similar behavior (Figure 4H).
Finally, we confirmed that the washed fabrics, which
retained their zinc content after 50 washes (Table 3), were
still able to reduce virus titers and incubated 0.4 g of unwashed
or washed fabric with a fixed amount of IAV and removed
inactivated virus with PBSTE. Analysis of the virus titers
showed that both washed fabrics were able to reduce the IAV
titer by approximately 2-logs (Figure 4I). Overall, these results
suggest that the PA66 fabric containing zinc can inactivate
both IAV and SARS-CoV-2 and that this property is retained
after 50 washes. Given that zinc does not leach from the fibers,
we suggest that both viruses are inactivated following
adsorption to the solid fabric phase.
■ DISCUSSION
One way to fight RNA viruses is to limit respiratory virus
spread through efficient PPE. To better understand how
respiratory RNA viruses are adsorbed and inactivated on
fabrics, we here added IAV and SARS-CoV-2 to cotton, PA66,

















KF1 328 186 0.66 111 1.35
control 0 182 0.66 133 1.11
Table 2. Zinc Content in Leachate after Washing According
to AATCC Test Protocol 1-2018 as Measured by ICP-OESa
leachate solution Zn measured (ppm)
as prepared 0.149
stirred 30 min below detection limit
stirred 60 min below detection limit
aThe leachate was exposed to cation exchange resin for 30 or 60 min
under continuous stirring.
Table 3. Zinc Content in KG6 Fabric after Repeated
Washing According to the Standardized Home Laundry
Test Protocol AATCC M6-2016 as Measured by ICP-OES
no. of wash
cycles
Zn level (ppm) after
machine washes
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Figure 4. Inactivation of IAV and SARS-CoV-2 on fabrics. (A) Schematic of testing procedure for fabrics without or with embedded zinc oxide. (B)
Photo of fabric placed in Petri dish and exposed to 100 μL sample (dyed red). (C) IAV titer in input or PA66 control or KF1 fabric eluates. (D)
SARS-CoV-2 titer in input or PA66 control or KF1 fabric eluates. One representative experiment is shown. (E) Western blot analysis of IAV HA
and NP protein levels after exposure of IAV to the KF1 or control fabric. Both the virus that was removed (eluate) from each fabric with PBSTE as
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and PPP. We find strong liquid absorption by cotton and PA66
in PBS and that addition of tween-80 results in efficient virus
release from PA66 but not from cotton. A previous clinical trial
found that cotton masks with strong liquid absorbing
properties may be associated with a higher risk of infection
when reused and our finding that cotton does not release IAV
or SARS-CoV-2 efficiently after washing is in line with this
observation.16 By contrast, virus retention on PPP, which is
used for the construction of disposable 3-ply masks, is poor, in
line with its hydrophobic properties.34 This result implies that
respiratory viruses remain on the surface of these masks, in line
with findings that SARS-CoV-2 can survive up to 7 days on
PPP-based surgical face masks.19,36 However, PPP has
important favorable properties, such as good breathability,
filtration, and electrostatic properties and will thus have a
purpose in the right situation.
Zinc and copper ions can inactivate IAV and SARS-CoV-2
(Figures 2, 4).22,24,30 Using a zinc-containing PA66-based
fabric from which we could easily remove adsorbed virus with a
mild detergent (Figure 1), we consistently found a rapid
reduction in the titer of both viruses and at viral loads that far
exceed the number of infectious IAV particles present in a
cough (Figure 4). After washing the fabrics using a
standardized protocol, both the zinc content and the
inactivating properties of the PA66 fabric were retained,
suggesting that this fabric is reusable. This property may be of
particular importance for designing reusable, “pathogen-free”
PPE that could help reduce environmental waste, virus
transmission, and costs.
We also investigated the mechanism by which zinc ions
inactivate IAV and SARS-CoV-2. RT-qPCR analysis showed
no significant reduction in viral RNA integrity after treatment
with zinc ions. By contrast, analysis of the solubility of the viral
surface and capsid proteins revealed a reduced level of the virus
surface protein HA for IAV after exposure to zinc ions, while
no effect on the internal nucleoprotein protein was detected.
We observed a similar altered surface protein to nucleoprotein
ratio after exposure to the zinc-containing PA66 fabric KF1.
Together, these results suggest that the reduction in virus titer
after exposure to zinc ions derives from inactivation of the viral
surface proteins. This is in line with previous biochemical and
electron microscopy studies showing the effect on divalent
metals on viral protein stability and particle morphology.29,37
Research has shown that zinc and copper ions can also induce
oxidative reactions, inactivation of the viral proton channels,
local pH changes, or viral membrane destabilization, and we
cannot exclude that these processes may play a role in the
inactivation as well.31,38,39
■ CONCLUSIONS
Overall, we show that zinc ions can inactivate IAV H1N1 and
that a woven PA66 fabric containing zinc ions can decrease the
IAV H1N1 and pandemic SARS-CoV-2 titer by approximately
2-logs. This reduction is more than sufficient to inactivate the
number of infectious IAV particles (∼24 pfu) present in a
cough.32 Overall, these results provide insights into the
protective properties of fabrics and the development of testing
protocols for reusable “pathogen-free” fabrics. Our findings
may be important for healthcare workers who are exposed to
infected patients for prolonged periods, people with underlying
risk factors needing additional protection, and people who
need to frequently remove their PPE.
■ METHODS
Influenza Viruses and Cells. HEK 293T and MDCK cells were
originally sources from ATCC. Influenza A/WSN/33 (H1N1) virus
was produced by transfecting a 12-plasmid rescue system into HEK
293T cells.40 After 2 days, the P0 virus was amplified on MDCK cells
in minimal essential medium (MEM) containing 0.5% fetal bovine
serum (FBS) at 37 °C and 5% CO2. P1 and P2 viruses were aliquoted
and stored at −80 °C. For plaque assays, samples were serially diluted
in MEM containing 0.5% FBS. Diluted virus (μL) was next added to
confluent MDCK cells and incubated for 1 h 37 °C. After virus
adsorption to the MDCK cells, the inoculum was removed and
replaced with 2 mL of MEM/agarose overlay (MEM, 0.5% FBS, 1%
low-melt agarose). Plaques were grown for 2 days at 37 °C and then
fixed with 4% paraformaldehyde in PBS. Plaques were counter-stained
with 0.01% crystal violet in water and washed with tap water before
analysis.
Coronaviruses and Cells. SARS-CoV-2 (Bavpat-1 and USA-
WA1/2020) was grown on African Green Monkey kidney epithelial
Vero-E6 cells in Dulbecco’s minimal essential medium (DMEM)
supplemented with 10% FBS. For plaque assay analysis, Vero-E6 cells
were seeded in 12-well plates and infected at 100% confluency. Ten-
fold virus dilutions were grown under a 1% agarose overlay in DMEM
containing 0.5% FBS for 2 days at 37 °C. Plaque assays were fixed
with 4% paraformaldehyde in PBS and stained with 0.01% crystal
violet in water. Experiments were performed in the Mt Sinai BSL3 lab
according to the approved biosafety standards.
Cell Viability. To measure the effect of zinc ions or EDTA on the
viability of the MDCK and Vero E6 cells used for plaque assays, we
used a CellTiter Blue assay (Promega). Briefly, confluent cells were
incubated with MEM containing 0.5% FBS and varying concen-
trations of zinc or EDTA. After 24 h, the medium was replaced with
MEM containing 0.5% MEM and redox dye resazurin according to
the manufacturer’s instructions. Following conversion of resazurin to
the fluorescent resofurin by viable cells, the fluorescent signal was
measured using a 560 nm excitation wavelength and a 590 nm
emission wavelength on a SpectraMax plate reader.
Construction of Zinc-Containing PA66 Fabrics. The PA66
fabrics were made from 70 denier 68 filament draw-textured PA66
yarn, which was spun from PA66 polymer-containing embedded zinc
oxide (Microban Additive Zo7; EPA Reg. no. 42182-8). Zinc oxide
(0.065% w/w) was brought into an ionic form and incorporated into
Figure 4. continued
well as the virus that remained on each fabric was analyzed. (F) Western blot analysis of SARS-CoV-2 S and N protein levels after exposure of virus
to the KF1 or control fabric. Both the virus that was removed (eluate) from each fabric with PBSTE as well as the virus that remained on each
fabric was analyzed. G) Time course of IAV or SARS-CoV-2 titer reduction by the KF1 fabric minus the titer reduction by the PA66 control
without embedded zinc. One representative time course is shown. Data were fit with logarithmic equation. (H) Reduction rate of IAV or SARS-
CoV-2 titer after exposure to KF1 fabric. Data points were obtained by time course experiments in which we varied the viral load and subsequently
estimated the maximum reduction rate (exponential phase) for each time course. Reduction was normalized to pfu·gram−1·min−1 using the dry
fabric weight. IAV and SARS-CoV-2 data points were fit with a linear line, and no difference was observed between the two fits. R2 for IAV fit is
shown. (I) Reduction rate of IAV titer after exposure to unwashed or washed KG6 fabric. Error bars represent standard deviation. Asterisk indicates
p-value, with *p < 0.05 and ns p > 0.05.
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the polymer pellets prior to the polymerization step. The polymer was
made by Ascend Performance Materials in their facility in Pensacola,
FL, and it was subsequently spun as a yarn, draw-textured into a bulk
yarn, and then knitted on a circular knitting machine into a single
jersey fabric. The KF-1 fabric was dyed with Lanasyn Black S-DL-C p
120 (Anchroma USA, Inc) according to the manufacturer’s
instructions. The control and other fabrics tested were not dyed.
Washing and Zinc Content Analysis. For analysis of the zinc
release from the PA66 fabric, 1 kg of fabric containing 500 ppm zinc
was washed according to AATCC lab procedure 1-2018. After the
agitation cycle, a leachate sample was analyzed using ICP-OES to
measure the zinc content. Next, 50 g of leachate was mixed with 1 g of
cation exchange resin Lewatit TP 260 in H+ form and the remaining
zinc content of the supernatant measured using ICP-OES after 30
min. For analysis of zinc release following repeated washing, PA66
fabrics were washed according to the standardized home laundry test
protocol AATCC M6-2016. The zinc content in fabric samples was
analyzed by ICP-OES analysis. To test if zinc oxide had affected the
polymerization and yarn production process or whether zinc oxide
particles were present in the fibers, fabric samples with a thickness of
∼0.5 μm were taken using a Reichert Jung Ultramicrotome. Samples
were analyzed by SEM/TED at 30.0 kV at different magnifications.
Other Fabrics. The cotton fabric was issued and certified by the
IAC (lot number IACVC01012020). The PPP disposable type II 3-
ply face mask (Medical Products Co, Ltd) was BS EN14638:2019
type II compliant.
Virus Adsorption and Extraction. Fabrics were stored at room
temperature in sealed plastic bags. Prior to each experiment, fabric
samples were cut to size using scissors sterilized with 75% ethanol.
The size of the fabrics varied from 1 cm2 to 0.4 g, as indicated in the
figures. To test the ability of fabrics to reduce viral titers, we used a
modified ISO 18184 protocol. Briefly, 100 μL of IAV strain A/WSN/
33 (H1N1) was carefully applied to fabrics in 2−10 μL droplets that
were spread over each fabric in a serpentine pattern. After incubation
at room temperature as indicated, the fabrics were placed in 50 mL
tubes containing 900 μL of PBS, PBS containing different percentages
tween-80, or PBS containing 0.05% tween-80 and 10 mM EDTA.
Fabrics were washed by vortexing them inside the 50 mL tubes for
approximately 1 min. After centrifugation, all liquid was squeezed
from each fabric and the 1 cm fabrics transferred to an Eppendorf
tube containing 1 mL of Trizol (Invitrogen) to extract remaining viral
protein and RNA. Experiments were performed in triplicate, unless
noted otherwise. Data was analyzed in Graphpad Prism 8 using 1-way
ANOVA.
RT-qPCR and Western Blot. RNA extraction from Trizol was
performed as described previously,41 while protein was extracted from
the interphase using isopropanol precipitation.42 The precipitated
protein was washed in ethanol, resuspended in 5× SDS-PAGE loading
buffer, sonicated for 10 s, and boiled for 10 min before 8% SDS-PAGE
analysis. Western blot was performed using antibodies directed
against IAV HA (Invitrogen, PA5-34929) and NP (GeneTex,
GTX125989) and SARS-CoV-2 S (Abcam ab272504) and N
(GeneTex, GTX632269). Membranes were washed in TBS
containing 0.1% tween-20. Spike RNA was purchased from IDT
and had the sequence 5′-AGUAGAAACAAGGCGGUAGGCGCU-
GUCCUUUAUCCAGACAACCAUUACCUGUCCACACAAU-
CUGCCCUUUCGAAAGAUCCCAACGAAAAGAGAGACCA-
CAUGGUCCUUCCUGCUUUUGCU-3′. Isolated RNA was re-
verse-transcribed using SuperScript III and a primer binding to the
3′ end of the NA segment.41 qPCR was performed as described
previously.41 Data was analyzed in Graphpad Prism 8 using one-way
ANOVA with multiple corrections.
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